Genoway (XPAR:ALGEN) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALGEN Genoway SA XPAR:ALGEN
56 GF Score
Price €2.38
GF Value €2.92
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Genoway Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Genoway's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

XPAR:ALGEN vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Genoway's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genoway Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genoway's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Genoway's Margin of Safety % (DCF FCF Based) falls into.


XPAR:ALGEN
56GF Score
Genoway SA XPAR:ALGEN
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Genoway (XPAR:ALGEN) Overvalued in 2026?

Based on GuruFocus' analysis, Genoway stock appears to be undervalued. The current stock price of €2.38 is trading 18.5% below its estimated GF Value™ of €2.92. GuruFocus considers Genoway to be Modestly Undervalued.

Key valuation signals for XPAR:ALGEN:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €2.92 vs. price of €2.38 (18.5% below fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the XPAR:ALGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genoway Business Description

Other Exchanges JEH:Germany
Address 181-203 avenue Jean Jaures, Lyon, FRA, 69007
Genoway SA specializes in genetic designs to serve genetically modified (GM) mice, rat and cell lines for the biopharmaceutical industries and research industries.
56GF Score

Get the complete analysis for XPAR:ALGEN

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.38
Price
€2.92
GF Value